Radioembolization for the treatment of hepatocellular carcinoma
Hyo-Cheol Kim
Clin Mol Hepatol. 2017;23(2):109-114.   Published online 2017 May 10     DOI: https://doi.org/10.3350/cmh.2017.0004
Citations to this article as recorded by Crossref logo
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage
Alberta Cappelli, Paloma Sangro, Cristina Mosconi, Iris Deppe, Eleonora Terzi, Jose I. Bilbao, Macarena Rodriguez-Fraile, Caterina De Benedittis, Jens Ricke, Rita Golfieri, Bruno Sangro
European Journal of Nuclear Medicine and Molecular.2019; 46(3): 661.     CrossRef
Feasibility of Boosted Radioembolization for Hepatocellular Carcinoma Larger than 5 cm
Hyo-Cheol Kim, Yoon Jun Kim, Jeong-Hoon Lee, Kyung-Suk Suh, Jin Wook Chung
Journal of Vascular and Interventional Radiology.2019; 30(1): 1.     CrossRef
Expected and Unexpected Imaging Findings after 90Y Transarterial Radioembolization for Liver Tumors
Juan C. Spina, Isabel Hume, Ana Pelaez, Oscar Peralta, Marcos Quadrelli, Ricardo Garcia Monaco
RadioGraphics.2019; 39(2): 578.     CrossRef
Designing pH-triggered drug release iron oxide nanocomposites for MRI-guided photothermal-chemoembolization therapy of liver orthotopic cancer
Fengyong Liu, Xin Li, Yangyang Li, Yuchen Qi, Hongjun Yuan, Jian He, Wanlin Li, Min Zhou
Biomaterials Science.2019; 7(5): 1842.     CrossRef
Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know
Ijin Joo, Hyo-Cheol Kim, Gyoung Min Kim, Jin Chul Paeng
Korean Journal of Radiology.2018; 19(2): 209.     CrossRef
Yttrium-90 Radioembolization of the Right Inferior Phrenic Artery in 20 Patients with Hepatocellular Carcinoma
Hyo-Cheol Kim, Yoon Jun Kim, Jin Chul Paeng, Jin Wook Chung
Journal of Vascular and Interventional Radiology.2018; 29(4): 556.     CrossRef
Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenib
Maria Grazia LucĂ , Roberto Nani, Melanie Schranz, Massimo De Giorgio, Claudia Iegri, Roberto Agazzi, Francesco Sala, Giorgio Virotta, Donatella Sarti, Grazia Conte, Domenico Pinelli, Carlo Nicora, Michele Colledan, Sandro Sironi, Stefano Fagiuoli
Future Oncology.2018; 14(8): 727.     CrossRef
Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor
Song Yi Lee, Jin Woo Choi, Jae-Young Lee, Dae-Duk Kim, Hyo-Cheol Kim, Hyun-Jong Cho
Drug Delivery.2018; 25(1): 1472.     CrossRef
Hepatocellular carcinoma treatment: hurdles, advances and prospects
Ratna Kumari, Manoj Kumar Sahu, Anindita Tripathy, Kanishka Uthansingh, Manas Behera
Hepatic Oncology.2018; 5(2): HEP08.     CrossRef
Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
Aldona Kasprzak, Agnieszka Adamek
International Journal of Molecular Sciences.2018; 19(12): 3887.     CrossRef